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 Abstract 
  Background/Aims:  Decreased thrombopoiesis has been ascribed a role in the pathogenesis of 
uremic bleeding in chronic renal failure (CRF). However, serum thrombopoietin (TPO) levels are 
usually elevated in CRF patients, suggesting increased thrombopoiesis. The aim of this study 
was to determine the thrombopoietic activity in CRF.   Methods:   Male Sprague-Dawley rats that 
underwent 5/6 nephrectomy were used as the model of CRF. Age-matched sham-operated rats 
were used as controls. Single megakaryocytes were isolated from the rat bone marrow, and 
their size distribution was examined. Megakaryocyte membrane invaginations were monitored 
by confocal imaging of di-8-ANEPPS staining, and patch clamp whole-cell recordings of mem-
brane capacitance. TPO gene expression was assessed in various tissues.   Results:   Circulating 
platelet counts and the number of large megakaryocytes were increased in the bone marrow 
of CRF rats. Massive di-8-ANEPPS staining and increased membrane capacitance in large mega-
karyocytes demonstrated increased membrane invaginations. Unaffected Kv1.3-channel cur-
rents per cell surface area demonstrated unaltered channel densities. TPO transcription was 
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decreased in the renal cortex but increased in the liver and bone marrow of CRF rats.   Conclu-
sion:  Increased thrombopoiesis in CRF was thought to be a reactive mechanism to platelet dys-
function. Increased TPO production from the liver and bone marrow compensated for de-
creased production from damaged kidneys.    Copyright © 2011 S. Karger AG, Basel 
 Introduction 
  Chronic renal failure (CRF) has been associated with bleeding complications, defined 
as uremic bleeding   [1]  . Uremic bleeding is indicated by prolongation of bleeding times, be-
cause the major pathogenesis is platelet dysfunction with decreased aggregation and im-
paired adhesiveness   [2–4]  . Using the   75  Se-selenomethionine incorporation technique into 
platelets, Gafter et al.   [5]   demonstrated decreased thrombopoietic activity in CRF patients. 
Because circulating platelet counts were also decreased in some CRF patients   [5, 6]  , de-
creased thrombopoiesis has been associated with the pathogenesis of uremic bleeding. 
However, Sullivan and McDonald   [7]   found that platelet dysfunction is one of the stimula-
tors of reactive thrombopoiesis, and later reports have actually demonstrated elevated se-
rum thrombopoietin (TPO) levels in CRF patients  [6, 8] , suggesting increased thrombopoi-
esis in CRF, although it has not directly been examined in megakaryocytes, the site of 
thrombopoiesis.
    Recent advances in molecular biology have revealed that thrombopoiesis consists of 
two stages: initial invagination of the megakaryocyte membrane and later proplatelet re-
lease from enlarged megakaryocytes   [9–11]  . Patch clamp studies in living megakaryocytes 
have further demonstrated that membrane invaginations are best monitored by whole-cell 
capacitance measurements and confocal imaging of membrane-impermeant fluorescent 
indicators   [12–14]  . Here, using these approaches, we demonstrate for the first time that 
thrombopoietic activity is increased in CRF, which is thought to be a reactive mechanism 
to impaired platelet function. We also show that TPO production from the liver and bone 
marrow is increased in CRF, compensating for the decreased production from damaged 
kidneys.
  M e t h o d s  
 Animal  Preparation 
  Rats subjected to 5/6 nephrectomy were used as a model of CRF in the present study. 
Subtotal nephrectomy was performed in male Sprague-Dawley rats weighing 150–180 g (Ja-
pan SLC Inc., Shizuoka, Japan) as described in our previous studies  [15, 16] . Briefly, the upper 
1/3 and lower 1/3 of the right kidney was ligated to induce infarction. One week later, the left 
kidney was removed. During the subsequent 8-week recovery period, rats had free access to 
standard rat chow and water ad libitum, and were maintained in a humidity- and tempera-
ture-controlled room on a 12-hour light-dark cycle. Age-matched sham-operated rats were 
used as controls. At the end of the recovery period, the rats were deeply anesthetized with 
isoflurane, and then killed by cervical dislocation. Trunk blood was withdrawn for the mea-
surements of serum creatinine levels and platelet counts. Bone marrow was harvested from 
the femoral bones for megakaryocyte isolation and RNA extraction. Kidney, liver and spleen 
were removed for RNA extraction. All experimental protocols described in the present study 
were approved by the Ethics Review Committee for Animal Experimentation of the Tohoku 
University.149
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    Megakaryocyte Preparation and Size Distribution 
 Single megakaryocytes were isolated from rat bone marrow as described in our previous 
studies   [17–19]  . Briefly, bone marrow obtained from femoral bones was flushed with stan-
dard external solution containing (in m  M  ): NaCl, 145; KCl, 4.0; CaCl  2  , 1.0; MgCl  2  , 2.0, and 
HEPES, 5.0 (pH 7.2 adjusted with NaOH), and disseminated by repetitive pipetting. After 
removing large tissue pieces, cells were washed twice by gentle centrifugation for 1 min and 
resuspended in the standard external solution. They were maintained at room temperature 
(22–24    °    C) for use within 8 h.
    The megakaryocyte suspension was scattered in a chamber placed on the headstage of 
an inverted microscope (Nikon, Tokyo, Japan). Megakaryocytes were easily distinguishable 
from other cells by their large size and multilobed nucleus   [20]  . Bright-field images were ac-
quired from randomly selected 0.1-mm  2   fields of view (10 views from 6 sham-operated and 
6 CRF rats, respectively). Megakaryocyte sizes were determined by cell surface areas calcu-
lated from the diameters measured. Then differently sized megakaryocytes were counted in 
each field, and their frequencies, expressed as percentage of the total megakaryocyte number, 
were averaged.
  Di-8-ANEPPS  Staining 
 Single megakaryocytes were incubated for 30 min at room temperature in external solu-
tion containing styryl membrane indicator, di-8-ANEPPS (Biotium, Hayward, Calif., USA; 
final concentration 10    M ). Fluorescent images were taken using a TE 2000-E Nikon Eclipse 
confocal microscope (Nikon, Tokyo, Japan). 
    Electrical Setup and Patch Clamp Recordings 
  Single megakaryocytes were subjected to standard patch clamp whole-cell recording 
techniques, using an EPC-9 patch clamp amplifier system (Heka Electronics, Lambrecht, 
Germany), as described previously   [17–19]  . The patch pipette resistance was 1–3 M     when 
filled with internal (patch pipette) solution containing (in m  M ): KCl, 145; MgCl  2 , 1.0; EGTA, 
10, and HEPES, 5.0 (pH 7.2 adjusted with KOH). After gigaseal formation, we applied suction 
briefly to the pipette to rupture the patch membrane. The series resistance of whole-cell re-
cordings was maintained below 10 M     during experiments. 
    Membrane capacitance of megakaryocytes was determined during whole-cell record-
ings using an EPC-9 amplifier. We employed a sine plus DC protocol using the Lockin am-
plifier of the Pulse program. An 800-Hz sinusoidal command voltage was superimposed on 
the holding potential of –80 mV. Specific membrane capacitance was expressed per unit 
spherical cell surface area. All experiments were carried out at room temperature.
  Real-Time  RT-PCR 
 Total RNAs from freshly isolated renal cortex, outer and inner medulla, liver, spleen, and 
bone marrow were extracted using the RNeasy mini kit (Qiagen, Hilden, Germany). First-
stand cDNA was synthesized from 2    g of total RNA of each tissue in 20     l of reaction mix-
ture using the SuperScript VILO first-strand synthesis kit (Invitrogen, Carlsbad, Calif., 
USA). The quantitative RT-PCR was carried out using the Applied Biosystems 7500 Real-
Time PCR System (Life Technologies Inc., Gaithersburg, Md., USA) using SYBR Premix Ex 
Taq II (Takara Bio, Kyoto, Japan). The quantity of RNA samples was normalized by the ex-
pression level of GAPDH. The sequences of the primers are TPO, forward 5  -CCC AAG CAG 
AAC CTC TCA AC-3    , reverse 5    -TCA GGT ATC CAG GGA TTT GG-3     (200 bp), and 
GAPDH, forward 5    -GGC ACA GTC AAG GCT GAG AAT G-3    , and reverse 5   -ATG  GTG 
GTG AAG ACG CCA GTA-3     (143 bp).150
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    Other Measurements and Statistical Analyses 
  Serum creatinine levels were measured using a chemical autoanalyzer (DRI-CHEM 
3500V; Fuji, Tokyo, Japan), platelet counts using a blood cell counter (MICROS abc LC-152; 
Horiba, Tokyo, Japan). Data were analyzed using PulseFit software (HEKA Electronics), 
IGOR Pro (WaveMetrics, Lake Oswego, Oreg., USA) and Microsoft Excel (Microsoft Corpo-
ration, Redmond, Wash., USA) and reported as means   8   SEM. Statistical significance was 
assessed by two-way ANOVA followed by Dunnett’s or Student’s t test. A value of p   !   0.05 
was considered significant.
  R e s u l t s  
  Thrombocytosis in CRF Rats 
  As previously demonstrated in our studies   [15, 16]  , increased serum creatinine levels in 
CRF rats reflected renal dysfunction (  table 1  ). Due to the controversial reports on decreases/
increases in circulating platelet counts in CRF patients   [5, 6, 21, 22]  , we aimed to examine 
circulating platelet counts in our rat model of CRF and found that circulating platelet counts 
were significantly higher in CRF than sham-operated rats (  table 1  ), indicating reactive 
thrombocytosis.
    Megakaryocyte Size Distribution in Sham-Operated and CRF Rats 
  Because megakaryocytes are the precursors of platelets, we first examined their mor-
phological differences between sham-operated and CRF rats. Transparent megakaryocytes 
were excluded from the size distribution, because they represent damaged cells  [23] . Only the 
sizes of normal, intact megakaryocytes that were kept spherical were assessed (  fig. 1  a). De-
pending on their sizes, the cells were divided into three groups: small cells (cells with an area 
  ! 400    m 2  ); intermediate cells (400–1,000    m 2  ;   fig. 1  a, left), and large cells (  1 1,000    m 2 ; 
  fig. 1  a, right). In sham-operated rats, being consistent with a previous finding   [14]  , most of 
the megakaryocytes were of intermediate size (  fig. 1  b), with   !  10% being large megakaryo-
cytes. In CRF rats, the number of intermediate megakaryocytes was much smaller than in 
sham-operated rats (  fig. 1  b). However, in contrast, the number of large megakaryocytes was 
significantly greater ( 1 2-fold), suggesting that mature megakaryocytes are increased in CRF 
rats. The numbers of small megakaryocytes were comparable between sham-operated and 
CRF rats.
    Di-8-ANEPPS Staining and Membrane Capacitance Measurements in Intermediate and 
Large Megakaryocytes 
 The demarcation membrane system (DMS) provides the additional membranes required 
for the process of thrombopoiesis in megakaryocytes   [13]  . At the beginning of DMS, mega-
karyocyte membrane invaginations are increased   [9–11]  . In bright-field images, large mega-
Sham-operated rats
(n = 6)
CRF rats
(n = 6)
Serum creatinine, mg/dl 0.3380.02 2.9681.11*
Platelet counts, n/mm3 314,000831,100 587,000824,800*
V  alues are means 8 SEM.* p < 0.05 vs. sham-operated rats.
Table 1. C  irculating platelet 
counts151
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karyocytes appeared to have more wrinkles on their cell surface (  fig. 1  a, right). To examine 
whether there are invaginated plasma membranes in the process of thrombopoiesis, we per-
formed di-8-ANEPPS staining  [12] . This dye stained peripheral plasma membranes of inter-
mediate megakaryocytes ( fig. 2 a, left), whereas it penetrated deep into large megakaryocytes 
and stained the extranuclear cellular volume throughout (  fig. 2  a, right). 
    Because specific membrane capacitance expressed per unit spherical cell surface area 
reflects the amount of invaginated plasma membranes   [12, 14]  , we measured the whole-cell 
membrane capacitance in megakaryocytes (  fig. 2  b). Specific membrane capacitance was 
significantly greater in large than in intermediate megakaryocytes (12.16   8   0.91 vs. 9.19   8  
0.22    F/cm 2  , p   !   0.05). These results from di-8-ANEPPS staining and membrane capaci-
tance measurements both indicated that invaginated plasma membranes were increased in 
large megakaryocytes, suggesting increased thrombopoiesis in the bone marrow of the CRF 
rat. 
    Kv1.3-Channel Currents in Intermediate and Large Megakaryocytes  
 Megakaryocytes are rich in delayed rectifier K  + -channels that have recently been identi-
fied as Kv1.3  [14] . To examine whether increased membrane invaginations affect Kv1.3-chan-
nel currents in megakaryocytes, we conducted whole-cell patch clamp recordings of the cur-
rents in intermediate and large megakaryocytes (  fig. 3  ). In both sizes of megakaryocytes, 
voltage steps from a holding potential of –80 mV activated large transient outward currents 
  Fig. 1.   Megakaryocyte (MK) size 
distribution in sham-operated 
(sham) and CRF rats.   a   Bright-
f i e l d  i m a g e s  o f  b o n e  m a r r o w  
cells showing an intermediate-
sized (left, arrow) and a large-
sized megakaryocyte (right, ar-
row).   b   Frequency histogram of 
different-size megakaryocytes. 
The numbers of cells were ex-
pressed as percentages of the to-
tal megakaryocyte number in se-
lected bright fields.   *  p   !   0.05 vs. 
sham-operated rat bone marrow. 
Values are means   8   SEM (n = 
60: 10 views from 6 sham-operat-
ed and 6 CRF rats, respectively). 
Differences were analyzed by 
ANOVA followed by Dunnett’s 
or Student’s t test.   b
  a  152
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at potentials positive to about –40 mV (  fig. 3  a). However, each current amplitude was great-
er in large megakaryocytes, with a significant difference in a peak current at +80 mV (11.78 
  8   1.20 vs. 7.42   8   0.83 nA, p   !   0.05;   fig. 3  b). Then, we normalized the peak currents by 
spherical cell surface areas of megakaryocytes ( fig. 3 c), only to find the significant difference 
was lost. From these results, total Kv1.3-channel currents in large megakaryocytes were in-
creased with increasing membrane invaginations. However, the currents per cell surface area 
were unaffected, indicating unaltered channel densities. 
    Tissue TPO mRNA Abundance in Sham-Operated and CRF Rats 
 TPO is a growth factor that stimulates megakaryocyte maturation and promotes throm-
bopoiesis   [24]  . Because the localization of its mRNA expression indicates the site of its syn-
thesis, we examined TPO mRNA abundance in various organs, including the kidney, liver, 
spleen and bone marrow in sham-operated rats (  fig. 4  a). As previously demonstrated   [25]  , 
the highest expression was noted in the liver, followed by the renal cortex, and to a lesser ex-
tent the renal medulla, spleen and bone marrow. These results indicate that the liver was the 
major site of TPO production, and the renal cortex was another one.
    In CRF patients, serum TPO levels are elevated   [6, 8]  , indicating increased tissue TPO 
production. To determine the organs that are responsible for the TPO increase, we exam-
ined TPO mRNA expression in the renal cortex, liver, spleen and bone marrow from CRF 
rats, and results were compared with those in sham-operated rats (  fig. 4  b). In the renal cor-
tex, TPO mRNA expression was significantly lower in CRF rats than in sham-operated rats 
(  fig. 4  b, top left), indicating impaired TPO production from damaged kidneys. However, in 
the liver and bone marrow, TPO mRNA expression was significantly higher in CRF rats 
than in sham-operated rats ( fig. 4 b, top right and bottom right). In the spleen, its abundance 
was not significantly different between CRF and sham-operated rats (  fig. 4  b, bottom left). 
  Fig. 2.   P l a s m a  m e m b r a n e  i n -
vaginations in intermediate and 
large megakaryocytes (MK). 
  a   Typical confocal fluorescence 
images of di-ANEPPS-labeled 
intermediate (left) and large 
(right) megakaryocytes.   b   Spe-
cific membrane capacitance of 
megakaryocytes expressed per 
unit spherical cell surface area. 
   *     p  !  0.05 vs. intermediate mega-
karyocytes. Values are means  8  
SEM (n = 30). Differences were 
analyzed by ANOVA followed 
by Dunnett’s or Student’s t test.  
  a  
  b  153
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These results suggested that the liver and bone marrow were responsible for increased TPO 
production in CRF, and they compensated for decreased TPO production from damaged 
kidneys.
  Discussion 
  In the present study, the number of large megakaryocytes was increased in the bone 
marrow of CRF rats (  fig. 1  ). Membrane capacitance per cell surface area was higher in large 
than intermediate megakaryocytes (  fig. 2  b). These findings provided electrophysiological 
evidence for increased membrane invaginations. Because invagination of the plasma mem-
brane is an initial step of DMS in the process of thrombopoiesis   [9–11, 13]  , our results sug-
gested increased thrombopoietic activities in CRF rats. Previously, using the   75 Se-selenome-
thionine incorporation technique into platelets, decreased thrombopoietic activity has been 
demonstrated in CRF patients   [5]  . However, this approach was not a direct way to examine 
megakaryocyte activity. Moreover, results were not consistent with later findings that dem-
onstrated elevated TPO levels in CRF patients   [6, 8]  . In the present study, by directly moni-
toring plasma membrane invaginations of megakaryocytes, we demonstrated increased 
  Fig. 3.   Kv1.3-channel currents in intermediate and large megakaryocytes (MK).   a   Typical whole-cell cur-
rent traces at different voltages recorded in intermediate (left) and large (right) megakaryocytes. The cur-
rents were elicited by voltage steps from the holding potential of –80 to –40, 0, 40 and 80 mV, as depicted 
in the voltage protocol. Each pulse was applied for a 200-ms duration between 10-second intervals.   b  Peak 
current amplitudes for a voltage step to 80 mV obtained from the records in  a .  c  Normalized peak currents 
expressed per unit spherical cell surface area of megakaryocytes.   *      p   !   0.05 vs. intermediate megakaryo-
cytes. Values are means   8   SEM (n = 30). Differences were analyzed by ANOVA followed by Dunnett’s or 
Student’s t test. 
a
bc154
Nephron Extra 2011;1:147–156
 DOI:  10.1159/000333018 
EXTRA
  Kazama et al.: Thrombopoiesis in Uremic Rat Megakaryocytes 
www.karger.com/nne
    © 2011 S. Karger AG, Basel
  Published online: October 22, 2011 
thrombopoiesis in CRF rats. It was considered to be a reactive mechanism to platelet dys-
function caused by uremic toxins in CRF.
  Boguslowicz et al.  [26]  observed dominant distribution of small megakaryocytes and an 
increased nuclear/cytoplasmic ratio in CRF rat bone marrow. In the present study, although 
the number of small megakaryocytes was slightly increased in the bone marrow of CRF com-
pared to sham-operated rats ( fig. 1 b), the increase in large megakaryocytes was more marked. 
At the beginning of thrombopoiesis, megakaryocytes are enlarged as a result of increased 
membrane invaginations. Then, after releasing platelets from their cytoplasm, the mega-
  Fig. 4.   TPO mRNA abundance in 
sham-operated and CRF rats.   a   TPO 
mRNA abundance in the kidney [cor-
tex (CX) and outer (OM)/inner medulla 
(IM)], liver, spleen and bone marrow in 
sham-operated rats.   b   Comparison of 
tissue TPO mRNA abundance between 
sham-operated (sham) and CRF rats in 
the renal cortex (top, left), liver (top, 
right), spleen (bottom, left) and bone 
marrow (bottom, right).   *  p   !   0.05 vs. 
sham-operated rats. Values are means 
  8   SEM (n = 6). Differences were ana-
lyzed by ANOVA followed by Dunnett’s 
or Student’s t test.  
a
b155
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karyocytes finally reduce their size   [9–11]  . Therefore, both small megakaryocytes in their 
study and large megakaryocytes in our study represented cells with increased thrombopoi-
etic activity. Because megakaryocytes were alive in our cell preparation, some of them initi-
ated thrombopoiesis in a chamber, presenting large appearance.
    In the present study, although membrane invaginations were increased in large mega-
karyocytes, Kv1.3-channel currents per cell surface area were not affected (  fig. 3  c). This is 
consistent with a previous finding that the absence of Kv1.3-channels in megakaryocytes did 
not affect thrombopoiesis   [14]  . Because cellular K  +   efflux can be a driving force for Ca  2+   en-
try into the cell, the increased outward K  +   currents through the channels will elevate cyto-
solic Ca  2+   concentrations of megakaryocytes   [17]  . Therefore, unaltered Kv1.3-channel cur-
rents per cell surface area in large megakaryocytes indicated that the membrane invagina-
tions occurred without the increase in cytosolic Ca  2+   concentrations. In our previous study, 
we have demonstrated that membrane amphipaths, such as salicylate and chlorpromazine, 
induce plasma membrane curvature changes and, thus, membrane invaginations of mega-
karyocytes   [27]  . In CRF rats, some of the uremic toxins may work like these membrane am-
phipaths and directly increased megakaryocyte membrane invaginations without affecting 
cytosolic Ca  2+   concentrations.
    Tissue TPO production is usually controlled by circulating platelet counts   [28]  . Accord-
ing to Sungaran et al.   [25]  , decreased platelet counts will stimulate bone marrow TPO pro-
duction and, thus, elevate serum TPO levels. In the present study, however, despite the in-
crease in circulating platelet counts ( table 1 ), both bone marrow and hepatic TPO production 
was increased in CRF rats ( fig. 4 b). These results indicated that local TPO production in CRF 
rats was not likely to be controlled by circulating platelet counts. As a molecular mechanism 
of reactive thrombocytosis, proinflammatory cytokines such as IL-6 are known to stimulate 
hepatic TPO production   [29]  . Since CRF is in a state of chronic inflammation with elevated 
serum cytokine levels   [30]  , IL-6 may work as a stimulator of both hepatic and bone marrow 
TPO production in CRF rats. 
    In conclusion, by monitoring plasma membrane invaginations of CRF rat megakaryo-
cytes, this study demonstrated increased thrombopoietic activity in CRF. It was considered 
to be a reactive mechanism to platelet dysfunction caused by uremic toxins. Increased TPO 
production from the liver and bone marrow compensated for the decreased production from 
the damaged kidneys.
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